|Day Low/High||416.01 / 421.11|
|52 Wk Low/High||250.21 / 441.96|
Thermo Fisher plans to buy microscope maker FEI for about $4.2 billion and Jim Cramer says FEI shareholders should take the money and run.
Also, Thermo Fisher annouces an acquisition as takeover talks boost Valeant shares.
As Valeant launches allegations of improper financial reporting at its former CFO, experts say it ought to take a close look at the composition of its audit committee.
We would anticipate a breakout to upside; a decline below $130 would turn us neutral on TMO.
Stanley Black & Decker and Thermo Fisher provide an unfortunate lesson.
While we don't want to alarm readers, we are increasingly concerned around the market's movement heading into year-end.
The management recently gave a very upbeat presentation.
Traders can finally shift focus from macro headlines in Greece and China as earnings are in full swing with hundreds of companies expected to report quarterly results.
Traders can finally shift focus from macro headlines in Greece and China as earnings go into full swing next week with hundreds of companies expected to report quarterly results.
TMO is a buy after a strong close above the wedge downtrend line.
Pall Corporation (PLL) rocketed higher on reports the manufacturer of filtration systems is in the late stages of an auction.
MasterCard (MA) shares may be fairly priced, but the company continues to capitalize on the secular trend toward a cashless society.
Perspectives from Wall Street looks at how investors at any age can find opportunities in the health care sector.
Panera and Thermo Fisher may be in completely different industries, but they both are undervalued at these levels.
Here are healthcare stocks of all shares and sizes with strong charts.
Akers Biosciences makes rapid, point-of-care screening and testing products designed to rapidly bring health care information direct to the consumer or provider.